124 related articles for article (PubMed ID: 38320866)
21. HLA-G*01:04∼UTR3 Recipient Correlates With Lower Survival and Higher Frequency of Chronic Rejection After Lung Transplantation.
Di Cristofaro J; Reynaud-Gaubert M; Carlini F; Roubertoux P; Loundou A; Basire A; Frassati C; Thomas P; Gomez C; Picard C
Am J Transplant; 2015 Sep; 15(9):2413-20. PubMed ID: 25989360
[TBL] [Abstract][Full Text] [Related]
22. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after heart transplantation.
Omrani O; Alawwami M; Buraiki J; Selimovic N
Ann Saudi Med; 2018; 38(2):97-104. PubMed ID: 29620542
[TBL] [Abstract][Full Text] [Related]
23. Significance of HLA-matching and anti-HLA antibodies in heart transplant patients receiving induction therapy?
Gavroy B; Timmermans T; Van Caenegem O; Mastrobuoni S; Jacquet L; Latinne D; Poncelet AJ
Transpl Immunol; 2022 Dec; 75():101706. PubMed ID: 36113729
[TBL] [Abstract][Full Text] [Related]
24. Human leukocyte antigen epitope mismatch loads and the development of de novo donor-specific antibodies in cardiothoracic organ transplantation.
Bedford A; Jervis S; Worthington J; Lowe M; Poulton K
Int J Immunogenet; 2022 Feb; 49(1):30-38. PubMed ID: 34904369
[TBL] [Abstract][Full Text] [Related]
25. HLA, Non-HLA Antibodies, and Eplet Mismatches in Pediatric Liver Transplantation: Observations From a Small, Single-Center Cohort.
Ekong UD; Antala S; Bow L; Sese D; Morotti R; Rodriguez-Davalos M; Gan G; Deng Y; Emre SH
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):6-17. PubMed ID: 30777518
[TBL] [Abstract][Full Text] [Related]
26. Association of Predicted HLA T-Cell Epitope Targets and T-Cell-Mediated Rejection After Kidney Transplantation.
Senev A; Van Loon E; Lerut E; Coemans M; Callemeyn J; Daniëls L; Kerkhofs J; Koshy P; Kuypers D; Lamarthée B; Sprangers B; Tinel C; Van Craenenbroeck AH; Van Sandt V; Emonds MP; Naesens M
Am J Kidney Dis; 2022 Dec; 80(6):718-729.e1. PubMed ID: 35690154
[TBL] [Abstract][Full Text] [Related]
27. HLA-DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity.
Wiebe C; Kosmoliaptsis V; Pochinco D; Gibson IW; Ho J; Birk PE; Goldberg A; Karpinski M; Shaw J; Rush DN; Nickerson PW
Am J Transplant; 2019 Jun; 19(6):1708-1719. PubMed ID: 30414349
[TBL] [Abstract][Full Text] [Related]
28. Acute antibody-mediated rejection in ABO-compatible pediatric liver transplant recipients: case series and review of the literature.
Wozniak LJ; Naini BV; Hickey MJ; Bhattacharyya S; Reed EF; Busuttil RW; Farmer DG; Vargas JH; Venick RS; McDiarmid SV
Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27597379
[TBL] [Abstract][Full Text] [Related]
29. Class II Human Leukocyte Antigen Epitope Mismatch Predicts De Novo Donor-Specific Antibody Formation After Liver Transplantation.
Kubal CA; Mangus R; Ekser B; Mihaylov P; Ceballos B; Higgins N; Chalasani N; Ghabril M; Nephew L; Lobashevsky A
Liver Transpl; 2018 Aug; 24(8):1101-1108. PubMed ID: 30142248
[TBL] [Abstract][Full Text] [Related]
30. Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantation.
Huang Y; Ramon D; Luan FL; Sung R; Samaniego M
Clin Transpl; 2012; ():247-56. PubMed ID: 23721029
[TBL] [Abstract][Full Text] [Related]
31. De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival.
Smith JD; Banner NR; Hamour IM; Ozawa M; Goh A; Robinson D; Terasaki PI; Rose ML
Am J Transplant; 2011 Feb; 11(2):312-9. PubMed ID: 21219570
[TBL] [Abstract][Full Text] [Related]
32. Human leukocyte antigen eplet mismatching is associated with increased risk of graft loss and rejection after pediatric heart transplant.
Albers EL; Friedland-Little JM; Hong BJ; Kemna MS; Warner P; Law YM
Pediatr Transplant; 2022 Feb; 26(1):e14126. PubMed ID: 34476876
[TBL] [Abstract][Full Text] [Related]
33. Adequate tacrolimus exposure modulates the impact of HLA class II molecular mismatch: a validation study in an American cohort.
Davis S; Wiebe C; Campbell K; Anobile C; Aubrey M; Stites E; Grafals M; Pomfret E; Nickerson P; Cooper JE
Am J Transplant; 2021 Jan; 21(1):322-328. PubMed ID: 32888256
[TBL] [Abstract][Full Text] [Related]
34. Combined Analysis of HLA Class II Eplet Mismatch and Tacrolimus Levels for the Prediction of De Novo Donor Specific Antibody Development in Kidney Transplant Recipients.
Lee H; Min JW; Kang H; Lee H; Eum SH; Park Y; Yang CW; Chung BH; Oh EJ
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806362
[TBL] [Abstract][Full Text] [Related]
35. Early donor-specific antibodies in lung transplantation: risk factors and impact on survival.
Ius F; Sommer W; Tudorache I; Kühn C; Avsar M; Siemeni T; Salman J; Hallensleben M; Kieneke D; Greer M; Gottlieb J; Haverich A; Warnecke G
J Heart Lung Transplant; 2014 Dec; 33(12):1255-63. PubMed ID: 25070908
[TBL] [Abstract][Full Text] [Related]
36. Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver.
Abu-Elmagd KM; Wu G; Costa G; Lunz J; Martin L; Koritsky DA; Murase N; Irish W; Zeevi A
Am J Transplant; 2012 Nov; 12(11):3047-60. PubMed ID: 22947059
[TBL] [Abstract][Full Text] [Related]
37. HLA-DQ eplet mismatch load may identify kidney transplant patients eligible for tacrolimus withdrawal without donor-specific antibody formation after mesenchymal stromal cell therapy.
Bezstarosti S; Meziyerh S; Reinders MEJ; Voogt-Bakker K; Groeneweg KE; Roelen DL; Kers J; de Fijter JW; Heidt S
HLA; 2023 Jul; 102(1):3-12. PubMed ID: 36841928
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of antibodies to lung self-antigens (Kα1 tubulin and collagen V) and donor specific antibodies to HLA in lung transplant recipients and implications for lung transplant outcomes: Single center experience.
Rao U; Sharma M; Mohanakumar T; Ahn C; Gao A; Kaza V
Transpl Immunol; 2019 Jun; 54():65-72. PubMed ID: 30794945
[TBL] [Abstract][Full Text] [Related]
39. The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes.
Freitas MC; Rebellato LM; Ozawa M; Nguyen A; Sasaki N; Everly M; Briley KP; Haisch CE; Bolin P; Parker K; Kendrick WT; Kendrick SA; Harland RC; Terasaki PI
Transplantation; 2013 May; 95(9):1113-9. PubMed ID: 23514959
[TBL] [Abstract][Full Text] [Related]
40. Role of
Chowdhry M; Patel M; Thakur Y; Sharma V
Asian J Transfus Sci; 2019; 13(2):136-139. PubMed ID: 31896922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
